ID   SW13/cl.2 vim-
AC   CVCL_WY52
SY   SW13 Cl.2 Vim-; SW-13/cl.2 vim-; SW13 Vim-
DR   EFO; EFO_0022566
DR   cancercelllines; CVCL_WY52
DR   Wikidata; Q98132909
RX   PubMed=1696263;
RX   PubMed=10388528;
CC   Population: Caucasian.
CC   Characteristics: Does not express vimentin.
CC   Sequence variation: Mutation; HGNC; 11100; SMARCA4; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV001436624; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0542 ! SW13
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 9
//
RX   PubMed=1696263; DOI=10.1083/jcb.111.2.553; PMCID=PMC2116208;
RA   Sarria A.J., Nordeen S.K., Evans R.M.;
RT   "Regulated expression of vimentin cDNA in cells in the presence and
RT   absence of a preexisting vimentin filament network.";
RL   J. Cell Biol. 111:553-565(1990).
//
RX   PubMed=10388528; DOI=10.1006/excr.1999.4479;
RA   Macioce P., Gandolfi N., Leung C.L., Chin S.S.M., Malchiodi-Albedi F.,
RA   Ceccarini M., Petrucci T.C., Liem R.K.H.;
RT   "Characterization of NF-L and betaIISigma1-spectrin interaction in
RT   live cells.";
RL   Exp. Cell Res. 250:142-154(1999).
//